STOCK TITAN

Health Catalyst Leader Appointed to Primary Care and Chronic Illness Standing Committee

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Health Catalyst (Nasdaq: HCAT) announced the re-appointment of Stephen Grossbart, Ph.D., as a member of the National Quality Forum's Primary Care and Chronic Illness Standing Committee on Jan. 11, 2021. Grossbart has been on the committee since 2017, contributing to significant healthcare quality measures amid ongoing challenges like the coronavirus pandemic. The committee oversees important healthcare measures, crucial for improving treatment outcomes for chronic and infectious diseases.

Positive
  • Re-appointment of Stephen Grossbart strengthens Health Catalyst's involvement in healthcare quality measures.
  • Committee's focus on improving chronic and infectious disease care aligns with national healthcare priorities.
Negative
  • None.

SALT LAKE CITY, Jan. 11, 2021 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Stephen Grossbart, Ph.D., Senior Vice President of Professional Services, has been re-appointed to National Quality Forum's (NQF) Primary Care and Chronic Illness Standing Committee.

Grossbart has served on the Committee since 2017 and its precursor, Pulmonary and Critical Care Standing Committee, since 2012.

Commenting on the appointment, Grossbart said: "As our nation continues to face the unprecedented challenges of the coronavirus, the implementation and effectiveness of healthcare quality measures and improvement strategies is of special importance. It's an honor to be named to NQF's Primary Care and Chronic Illness Standing Committee and I look forward to partnering with my fellow committee members to develop and advise on measures that will best support healthcare stakeholders and drive measurable improvements."

Members of the Primary Care and Chronic Illness Standing Committee are responsible for overseeing measures related to endocrine, infectious disease, musculoskeletal and pulmonary care. Measures endorsed by NQF are a benchmark for healthcare measurement in the United States and are critically important to healthcare outcomes improvement and efforts to treat and prevent chronic illness and infectious disease.

About Health Catalyst

Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations committed to being the catalyst for massive, measurable, data-informed healthcare improvement. Its customers leverage the cloud-based data platform—powered by data from more than 100 million patient records and encompassing trillions of facts—as well as its analytics software and professional services expertise to make data-informed decisions and realize measurable clinical, financial, and operational improvements. Health Catalyst envisions a future in which all healthcare decisions are data informed.

Media Contact:
Amanda Hundt
amanda.hundt@healthcatalyst.com
575-491-0974

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/health-catalyst-leader-appointed-to-primary-care-and-chronic-illness-standing-committee-301204733.html

SOURCE Health Catalyst

FAQ

What is Health Catalyst's recent press release about?

Health Catalyst announced the re-appointment of Stephen Grossbart to the National Quality Forum's Primary Care and Chronic Illness Standing Committee.

Who is Stephen Grossbart?

Stephen Grossbart, Ph.D., is the Senior Vice President of Professional Services at Health Catalyst and has been re-appointed to a key healthcare committee.

What does the National Quality Forum's Standing Committee focus on?

The committee oversees healthcare measures related to chronic and infectious diseases, crucial for improving healthcare outcomes.

When was the press release issued?

The press release was issued on January 11, 2021.

What is the significance of Grossbart's re-appointment for HCAT investors?

Grossbart's re-appointment enhances Health Catalyst's influence in healthcare quality, potentially benefiting its market position.

Health Catalyst, Inc

NASDAQ:HCAT

HCAT Rankings

HCAT Latest News

HCAT Stock Data

452.71M
59.17M
2.78%
90.41%
4.67%
Health Information Services
Services-computer Programming, Data Processing, Etc.
Link
United States of America
SOUTH JORDAN